ASPN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Aspen Aerogels Inc (ASPN) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company's financial performance is severely negative, insider selling is high, and there are no strong positive catalysts or trading signals to justify an investment at this time.
The technical indicators suggest a bearish trend. The MACD is negative and expanding downward, the RSI is neutral at 43.601, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key resistance levels, with a pivot at 3.145 and support at 2.595.
NULL. While there is some optimism for revenue growth in 2026 due to subsea projects, this is overshadowed by the company's poor financial health and strategic review.
Insider selling has increased by 288.04% over the last month.
The company reported a $291.2 million impairment charge and is under investigation for potential violations of federal securities laws.
Q4 2025 financials showed a 66% revenue drop, a net loss of $72.9 million, and a gross margin of -55.47%.
The company has initiated a strategic review, signaling uncertainty about its future direction.
Aspen Aerogels reported a disastrous Q4 2025 with revenue down 66.42% YoY to $41.3 million, a net income drop of 741.73% YoY to -$72.9 million, and EPS down 728.57% YoY to -$0.88. Gross margin also dropped significantly to -55.47%. The company posted a full-year net loss of $389.6 million for 2025.
No recent analyst ratings or price target changes were provided. However, the company's poor financial performance and lack of positive catalysts are likely to weigh on analyst sentiment.
